[1] Ohtsuka T, Nakanishi H, Ikeda W, et al. Nexilin: a novel actin filament-binding protein localized at cell-matrix adherens junction[J]. J Cell Biol, 1998,143(5):1227-1238. DOI: 10.1083/jcb.143.5.1227.
[2] Zhu B, Rippe C, Holmberg J, et al. Nexilin/NEXN controls actin polymerization in smooth muscle and is regulated by myocardin family coactivators and YAP[J]. Sci Rep, 2018,8(1):13025. DOI: 10.1038/s41598-018-31328-2.
[3] Pan D. The hippo signaling pathway in development and cancer[J]. Dev Cell, 2010,19(4):491-505. DOI: 10.1016/j.devcel.2010.09.011.
[4] 苏丽萍,季敏,路子扬,等.AJUBA调控MST1 YAP1和TAZ因子促进食管鳞状细胞癌细胞体外增殖迁移和侵袭[J].中国肿瘤临床,2022,49(7):331-337.DOI:10.12354/j.issn. 1000-8179.2022.20211829.
[5] Sansores-Garcia L, Bossuyt W, Wada K, et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway[J]. EMBO J, 2011,30(12):2325-2335. DOI: 10.1038/emboj.2011.157.
[6] Dupont S, Morsut L, Aragona M, et al. Role of YAP/TAZ in mechanotransduction[J]. Nature, 2011, 474(7350):179-183. DOI: 10.1038/nature10137.
[7] Daoud F, Holmberg J, Alajbegovic A, et al. Inducible deletion of YAP and TAZ in adult mouse smooth muscle causes rapid and lethal colonic pseudo-obstruction[J]. Cell Mol Gastroenterol Hepatol, 2021,11(2):623-637. DOI: 10.1016/j.jcmgh.2020.09.014.
[8] Zhu B, Ekman M, Svensson D, et al. Array profiling reveals contribution of Cthrc1 to growth of the denervated rat urinary bladder[J]. Am J Physiol Renal Physiol, 2018,314(5):F893-F905. DOI: 10.1152/ajprenal.00499.2017.
[9] Aherrahrou Z, Schlossarek S, Stoelting S, et al. Knock-out of nexilin in mice leads to dilated cardiomyopathy and endomyocardial fibroelastosis[J]. Basic Res Cardiol, 2016,111(1):6. DOI: 10.1007/s00395-015-0522-5.
[10] Wang H, Li Z, Wang J, et al. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy[J]. Am J Hum Genet, 2010,87(5):687-693. DOI: 10.1016/j.ajhg.2010.10.002.
[11] 卫曼曼,肖童,陈曦,等.ARNI与ACEI对急性失代偿心力衰竭患者心室重构及Nexilin、CPP的影响[J].中国老年学杂志,2022,42(10):2324-2327.DOI:10.3969/j.issn.1005-9202. 2022.10.005.
[12] Zhu B, Rippe C, Thi Hien T, et al. Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle[J]. PLoS One, 2017,12(5):e0176759. DOI: 10.1371/journal.pone.0176759.
[13] Krawczyk KK, Yao Mattisson I, Ekman M, et al. Myocardin family members drive formation of caveolae[J]. PLoS One, 2015,10(8):e0133931. DOI: 10.1371/journal.pone. 0133931.
[14] 刘胜来,田大伟,吴长利.梗阻性膀胱逼尿肌功能失调分子机制的研究进展[J].基础医学与临床,2022,42(10):1606-1610.DOI:10.16352/j.issn.1001-6325.2022. 10.1606.
[15] 刘涛,徐娟,张立,等.上调Yes相关蛋白1表达抑制动脉夹层血管平滑肌细胞凋亡的研究[J].中华实验外科杂志,2018,35(10):1834-1838.DOI:10.3760/cma.j.issn.1001-9030. 2018.10.015.
[16] 杨振,张红珠,张伟,等.Yes相关蛋白1对胃癌顺铂化疗敏感性的影响及作用机制初探[J].国际医药卫生导报,2021,27(21):3381-3387.DOI:10.3760/cma.j.issn.1007-1245. 2021.21.025.
[17] Byun J, Del Re DP, Zhai P, et al. Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload[J]. J Biol Chem, 2019,294(10):3603-3617. DOI: 10.1074/jbc.RA118.006123.
[18] Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer[J]. EMBO Rep, 2014,15(6):642-656. DOI: 10.15252/embr.201438638.
[19] Yu FX, Zhao B, Panupinthu N, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling[J]. Cell, 2012,150(4):780-791. DOI: 10.1016/j.cell.2012.06.037.
[20] Miller E, Yang J, DeRan M, et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP[J]. Chem Biol, 2012,19(8):955-962. DOI: 10.1016/j.chembiol.2012.07.005.
[21] Davis JR, Tapon N. Hippo signalling during development[J]. Development, 2019,146(18):dev167106. DOI: 10.1242/dev.167106.
|